Drug Pipeline

Fluvoxamine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
2
Phase 3
3
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-10 NCT07359482
sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19		 Recruitment opened
2026-06-10 NCT07359482
sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19		 date change Primary completion pushed: 2027-03-01 -> 2027-12-31
Active Studies by Phase
Phase 3
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06969287 Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery Delirium Recruiting
NCT07359482 sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19 Post-COVID Recruiting
Not specified
NCT03511118 Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed… Lactating Women on Select DOI Recruiting
Sponsors Running Fluvoxamine Trials
Duke University (1) Washington University School of Medicine (1) Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)
Get alerts when Fluvoxamine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free